IP Library › Granted Patent US 10,959,981
Granted Patent B2
US 10,959,981 · App. 15/989,544 · Granted Mar 30, 2021

Composition for preventing or treating climacteric symptoms comprising soybean extract comprising coumestrol as an active ingredient

Inventors: Hyun Jung Shin (Yongin-si, KR); Hyun Woo Jeong (Yongin-si, KR); Ji Hae Lee (Yongin-si, KR); Dae Jin Min (Yongin-si, KR); Dae Bang Seo (Yongin-si, KR); Sang Jun Lee (Yongin-si, KR)
Assignee: AMOREPACIFIC CORPORATION
A61K31/37A61K36/48A23V2002/00A61K2236/19
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,959,981
App. No.
15/989,544
Granted
Mar 30, 2021
Kind
B2
Abstract

The present invention relates to a composition for, inter alia, preventing or treating a climacteric disease, or preventing or improving a climacteric skin symptom comprising a soybean extract comprising coumestrol as an active ingredient, and more specifically relates to a composition for, inter alia, preventing or treating a climacteric disease, or preventing or improving a climacteric skin symptom comprising a germinated and fermented soybean extract comprising coumestrol as an active ingredient.

Claims (10)

1. A method for preventing or improving a climacteric skin symptom, wherein the method comprises administering an effective amount of a germinated and fermented bean extract comprising coumestrol to a subject in need thereof, wherein the method is for preventing or improving a climacteric skin symptom, which is UV-induced skin irritation, and

wherein the fermentation is performed by contacting the germinated bean with Aspergillus oryzae.

2. The method according to claim 1 , wherein the germinated and fermented bean is a bean which has been germinated and fermented simultaneously or sequentially.

3. The method according to claim 1 , wherein the bean has been germinated and then fermented.

4. The method according to claim 1 , wherein the germination is performed by germinating 1-50 vol % of the bean in a reactor comprising 20-80 vol % of a medium based on the total volume of the reactor.

5. The method according to claim 1 , wherein the germination is performed at 20-35° C. under a dark condition for 2-10 days.

6. The method according to claim 1 , wherein the germinated and fermented bean extract comprising coumestrol is administered in form of a composition comprising 0.0001-10 wt % of the germinated and fermented bean extract comprising coumestrol based on the total weight of the composition.

7. The method according to claim 1 , wherein the germinated and fermented bean extract comprising coumestrol is administered in form of a pharmaceutical composition.

8. The method according to claim 1 , wherein the germinated and fermented bean extract comprising coumestrol is administered in form of a health food composition.

9. The method according to claim 1 , wherein the germinated and fermented bean extract comprising coumestrol is administered in form of a cosmetic composition.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 25, 2018
From: SHIN, HYUN JUNG; JEONG, HYUN WOO; LEE, JI HAE; MIN, DAE JIN; SEO, DAE BANG; LEE, SANG JUN
To: AMOREPACIFIC CORPORATION
Reel/Frame 045903/0095 →
Priority Claims (1)
KR 10-2014-0053471 · May 2, 2014 · national
Continuity (2)
Division 14888623
Related Publication 20180271830A1 · Sep 27, 2018
Cited By (1)
US 12,569,422